Azenta/$AZTA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Azenta
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Ticker
$AZTA
Sector
Primary listing
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,000
ISIN
US1143401024
Website
Azenta Metrics
BasicAdvanced
$1.4B
-
-$1.36
1.64
-
Price and volume
Market cap
$1.4B
Beta
1.64
52-week high
$63.58
52-week low
$23.91
Average daily volume
906K
Financial strength
Current ratio
3.22
Quick ratio
2.165
Long term debt to equity
3.156
Total debt to equity
3.156
Profitability
EBITDA (TTM)
17.734
Gross margin (TTM)
41.72%
Net profit margin (TTM)
-9.77%
Operating margin (TTM)
-9.14%
Effective tax rate (TTM)
-3.36%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-1.66%
Return on equity (TTM)
-8.58%
Valuation
Price to revenue (TTM)
2.146
Price to book
0.81
Price to tangible book (TTM)
1.51
Price to free cash flow (TTM)
36.718
Free cash flow yield (TTM)
2.72%
Free cash flow per share (TTM)
81.54%
Growth
Revenue change (TTM)
8.56%
Earnings per share change (TTM)
-46.77%
3-year revenue growth (CAGR)
6.68%
10-year revenue growth (CAGR)
2.92%
3-year earnings per share growth (CAGR)
-64.19%
10-year earnings per share growth (CAGR)
14.13%
What the Analysts think about Azenta
Analyst ratings (Buy, Hold, Sell) for Azenta stock.
Bulls say / Bears say
Azenta's recent acquisition of B Medical Systems for approximately €410 million is expected to enhance its product offerings and expand its market reach, potentially driving revenue growth. (seekingalpha.com)
The company's strong balance sheet, with a balance sheet rank of 8/10, indicates robust financial health, providing a solid foundation for future investments and growth initiatives. (finance.yahoo.com)
Analyst upgrades, such as Stephens' upgrade to 'Overweight' with a price target of $60, reflect positive sentiment and confidence in Azenta's growth prospects. (marketscreener.com)
Azenta's profitability and growth ranks both stand at 4/10, suggesting challenges in achieving consistent profitability and growth. (finance.yahoo.com)
The stock's valuation is categorized as a 'Possible Value Trap,' indicating that investors should exercise caution due to potential overvaluation concerns. (finance.yahoo.com)
Despite recent acquisitions, Azenta's stock has lost nearly 60% of its value over the past year, raising concerns about its ability to deliver shareholder value. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Azenta Financial Performance
Revenues and expenses
Azenta Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Azenta stock?
Azenta (AZTA) has a market cap of $1.4B as of June 21, 2025.
What is the P/E ratio for Azenta stock?
The price to earnings (P/E) ratio for Azenta (AZTA) stock is 0 as of June 21, 2025.
Does Azenta stock pay dividends?
No, Azenta (AZTA) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next Azenta dividend payment date?
Azenta (AZTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Azenta?
Azenta (AZTA) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.